Growing evidence suggests that TACC3 is found overexpressed in many human cancers, including ovarian cancer, breast cancer, squamous cell carcinoma, and lung cancer [17], [18], [25], [26]. This evidence concerns the gene TACC3 and ovarian carcinoma.